ON Semiconductor Co. (NASDAQ:ON) Receives Average Recommendation of "Buy" from Analysts

Thursday, April 8, 2021 | MarketBeat

ON Semiconductor Co. (NASDAQ:ON) has earned a consensus recommendation of "Buy" from the twenty-seven research firms that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation, fourteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $36.04.

ON has been the topic of several research reports. BMO Capital Markets increased their price target on shares of ON Semiconductor from $25.00 to $35.00 and gave the stock a "market perform" rating in a research report on Monday, February 1st. They noted that the move was a valuation call. Benchmark increased their price target on shares of ON Semiconductor from $36.00 to $45.00 and gave the stock a "buy" rating in a research report on Tuesday, February 2nd. TheStreet raised shares of ON Semiconductor from a "c" rating to a "b-" rating in a research report on Monday, February 1st. Bank of America upgraded shares of ON Semiconductor from an "underperform" rating to a "buy" rating and set a $48.00 target price on the stock in a research note on Monday, March 1st. Finally, Summit Insights lowered shares of ON Semiconductor from a "buy" rating to a "hold" rating in a research note on Tuesday, February 16th.

In other news, EVP Vince Craig Hopkin sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, March 19th. The shares were sold at an average price of $39.26, for a total transaction of $39,260.00. Following the transaction, the executive vice president now directly owns 133,924 shares in the company, valued at $5,257,856.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Emmanuel T. Hernandez sold 74,165 shares of the firm's stock in a transaction that occurred on Monday, March 8th. The stock was sold at an average price of $37.73, for a total transaction of $2,798,245.45. Following the transaction, the director now owns 103,461 shares in the company, valued at $3,903,583.53. The disclosure for this sale can be found here. Corporate insiders own 1.42% of the company's stock.

Several institutional investors and hedge funds have recently made changes to their positions in ON. Baillie Gifford & Co. purchased a new position in shares of ON Semiconductor during the fourth quarter worth approximately $27,000. Jackson Grant Investment Advisers Inc. acquired a new stake in shares of ON Semiconductor during the fourth quarter worth $32,000. International Assets Investment Management LLC acquired a new stake in shares of ON Semiconductor during the fourth quarter worth $43,000. Capital Asset Advisory Services LLC acquired a new stake in shares of ON Semiconductor during the fourth quarter worth $43,000. Finally, Childress Capital Advisors LLC acquired a new stake in shares of ON Semiconductor during the fourth quarter worth $58,000. Institutional investors and hedge funds own 98.89% of the company's stock.

NASDAQ ON opened at $42.93 on Thursday. The firm's 50-day moving average is $40.17 and its two-hundred day moving average is $32.69. ON Semiconductor has a 12 month low of $12.69 and a 12 month high of $44.59. The company has a debt-to-equity ratio of 1.03, a current ratio of 2.11 and a quick ratio of 1.40. The stock has a market capitalization of $17.68 billion, a P/E ratio of 87.61, a PEG ratio of 5.67 and a beta of 1.99.

ON Semiconductor (NASDAQ:ON) last issued its quarterly earnings results on Sunday, January 31st. The semiconductor company reported $0.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.28 by $0.07. The business had revenue of $1.45 billion for the quarter, compared to analysts' expectations of $1.36 billion. ON Semiconductor had a net margin of 3.87% and a return on equity of 9.92%. During the same quarter in the prior year, the company earned $0.30 earnings per share. As a group, analysts anticipate that ON Semiconductor will post 0.77 EPS for the current year.

About ON Semiconductor

ON Semiconductor Corporation, together with its subsidiaries, manufactures and sells semiconductor components for various electronic devices worldwide. The company operates in three segments: Power Solutions Group (PSG), Advanced Solutions Group (ASG), and Intelligent Sensing Group (ISG). The PSG segment offers analog, discrete, module, and integrated semiconductor products for various applications, such as power switching, power conversion, signal conditioning, circuit protection, signal amplification, and voltage regulation functions.

Featured Story: Why do analysts give a neutral rating?

Analyst Recommendations for ON Semiconductor (NASDAQ:ON)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: How the Dogs of the Dow Strategy Works



7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.